scispace - formally typeset
M

Masamichi Kojiro

Researcher at Kurume University

Publications -  351
Citations -  21563

Masamichi Kojiro is an academic researcher from Kurume University. The author has contributed to research in topics: Hepatocellular carcinoma & Carcinoma. The author has an hindex of 74, co-authored 351 publications receiving 20418 citations. Previous affiliations of Masamichi Kojiro include Chiba University & Katholieke Universiteit Leuven.

Papers
More filters
Journal ArticleDOI

Angiogenesis in cancer.

TL;DR: There is an urgent need for a new comprehensive treatment strategy combining antiangiogenic agents with conventional cytoreductive treatments in the control of cancer.
Journal ArticleDOI

Prospective Cohort Study of Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma in 8510 Patients

TL;DR: TACE showed safe therapeutic modality with a 5-year survival of 26% for unresectable HCC patients and both the degree of liver damage and the tumor-node-metastasis (TNM) system proposed by the Liver Cancer Study Group of Japan demonstrated good stratification of survivals.
Journal ArticleDOI

Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version

TL;DR: The 2010 updated version of the Consensus-Based Clinical Practice Manual, based on both ‘evidence-based’ guidelines and the consensus of an expert panel on HCC, is summarized.
Journal ArticleDOI

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan

TL;DR: In this paper, the authors reviewed the standard results from each treatment based on an extensive survey and found that percutaneous ethanol injection (PEI), hepatic resection (HX), and transcatheter arterial embolization (TCAE) have all been used in the treatment of patients with small-sized hepatocellular carcinomas (HCCs).